In vivo anti-tumour activity of recombinant human tumour necrosis factor-alpha against Meth-A sarcoma requires L3T4-positive T cells

Ann Inst Pasteur Immunol. 1988 May-Jun;139(3):299-301. doi: 10.1016/0769-2625(88)90144-4.
No abstract available

MeSH terms

  • Animals
  • CD4-Positive T-Lymphocytes / immunology*
  • Mice
  • Sarcoma, Experimental / drug therapy
  • Sarcoma, Experimental / immunology
  • Tumor Necrosis Factor-alpha / pharmacology*

Substances

  • Tumor Necrosis Factor-alpha